Target intelligence / Profile preview

LYPLAL1 antisense RNA 1 (head to head) (LYPLAL1-DT)

Target
LYPLAL1-DT
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Divergent transcript
01

Overview

LYPLAL1 antisense RNA 1 (head to head) (LYPLAL1-DT, also known as LYPLAL1-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand adjacent to the protein-coding gene LYPLAL1 on chromosome 1q41[1][2][8]. It is classified as a divergent transcript and acts as an antisense lncRNA, but it does not encode a protein[1][7]. While its precise functions remain incompletely defined, LYPLAL1-DT may regulate the cell-type-specific expression of the adjacent LYPLAL1 gene in cis[3]. There are currently no known roles for this transcript as a therapeutic target, no approved drugs targeting it, and no established links to specific diseases or biomarker usage[1][2][3].

Other names
LYPLAL1-DTLYPLAL1-AS1LYPLAL1 divergent transcript
02

Biological functions

Likely regulates expression of adjacent LYPLAL1 gene in cisOther (specific biological roles remain poorly characterized)
03

Disease associations

Other (no direct disease associations documented)

Beyond the preview

Go deeper on LYPLAL1 antisense RNA 1 (head to head) (LYPLAL1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LYPLAL1 antisense RNA 1 (head to head) (LYPLAL1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call